Analyst Consensus
- Current Price
- 181.67 $
- Target (Low)
- 212.00 $
- Target (Mean)
- 260.81 $
- Target (High)
- 300.00 $
- Recommendation
- Buy
- Number of Analysts
- 26
Recommendation Distribution
Recommendation Distribution| Strong Buy | 9 |
|---|
| Buy | 15 |
|---|
| Hold | 4 |
|---|
| Sell | 0 |
|---|
| Strong Sell | 0 |
|---|
Key Ratios
- Net Profit Margin
- 11.6%
- Operating Margin
- 24.0%
- Gross Margin
- 63.3%
- Return on Equity (ROE)
- 18.0%
- Return on Assets (ROA)
- 5.9%
- Revenue Growth
- 10.6%
- Earnings Growth
- -12.0%
- Debt/Equity
- 218.57
- Current Ratio
- 1.09
- Beta
- 0.30
Recent Rating Changes
Recent Rating Changes| Date | Firm | Change |
|---|
| Apr 29, 2026 | JP Morgan | Overweight → Overweight |
| Apr 29, 2026 | TD Cowen | Buy → Buy |
| Apr 29, 2026 | RBC Capital | Outperform → Outperform |
| Apr 29, 2026 | Scotiabank | Sector Outperform → Sector Outperform |
| Apr 29, 2026 | Oppenheimer | Perform → Outperform |
| Apr 17, 2026 | Freedom Broker | Hold → Buy |